Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Knight

Showing results (971-980 of 1,143) with videos related to

Pageof 115
Sort By:
The Journal of Biological Chemistry|September 21, 2013
Reduction of synaptojanin 1 accelerates Aβ clearance and attenuates cognitive deterioration in an Alzheimer mouse modelLi Zhu, Minghao Zhong, Jiaying Zhao, et al.
Blood Advances|February 7, 2020
Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trialJennifer M Knight, J Douglas Rizzo, Parameswaran Hari, et al.
Cell Reports|November 19, 2023
Molecular annotation of G protein variants in a neurological disorderKevin M Knight, Elizabeth G Obarow, Wenyuan Wei, et al.
Annals of Clinical and Translational Neurology|February 17, 2025
High-Throughput Immunoassays for Cavin-4 IgG: A Diagnostic Tool for Immune-Mediated Rippling Muscle DiseaseReghann G LaFrance-Corey, Haidara Kherbek, Nimalan Harinesan, et al.
Ecology Letters|October 19, 2020
Seeing through the static: the temporal dimension of plant-animal mutualistic interactionsPaul J CaraDonna, Laura A Burkle, Benjamin Schwarz, et al.
Hepatology Communications|February 27, 2022
Preoperative portal vein recanalization-transjugular intrahepatic portosystemic shunt for chronic obliterative portal vein thrombosis: Outcomes following liver transplantationAbhinav Talwar, Jeffrey Varghese, Gabriel M Knight, et al.
JMIR Research Protocols|September 14, 2016
EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell AnemiaAngela E Rankine-Mullings, Courtney R Little, Marvin E Reid, et al.
Biomaterials|September 3, 2005
Multiple-channel scaffolds to promote spinal cord axon regenerationMichael J Moore, Jonathan A Friedman, Eric B Lewellyn, et al.
Journal of Clinical Microbiology|October 9, 2025
<i>In vitro</i> activity of antibiotic monotherapy and combination therapy with bacteriophages against <i>Staphylococcus aureus</i> LVAD-driveline infectionsMichèle M Molendijk, Nelianne J Verkaik, Corné P de Vogel, et al.
Communications Medicine|May 23, 2022
Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapyJennifer M Knight, Aniko Szabo, Igli Arapi, et al.
Pageof 115

Showing results (971-980 of 1,143) with videos related to

Sort By:
Pageof 115
The Journal of Biological Chemistry|September 21, 2013
Reduction of synaptojanin 1 accelerates Aβ clearance and attenuates cognitive deterioration in an Alzheimer mouse modelLi Zhu, Minghao Zhong, Jiaying Zhao, et al.
Blood Advances|February 7, 2020
Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trialJennifer M Knight, J Douglas Rizzo, Parameswaran Hari, et al.
Cell Reports|November 19, 2023
Molecular annotation of G protein variants in a neurological disorderKevin M Knight, Elizabeth G Obarow, Wenyuan Wei, et al.
Annals of Clinical and Translational Neurology|February 17, 2025
High-Throughput Immunoassays for Cavin-4 IgG: A Diagnostic Tool for Immune-Mediated Rippling Muscle DiseaseReghann G LaFrance-Corey, Haidara Kherbek, Nimalan Harinesan, et al.
Ecology Letters|October 19, 2020
Seeing through the static: the temporal dimension of plant-animal mutualistic interactionsPaul J CaraDonna, Laura A Burkle, Benjamin Schwarz, et al.
Hepatology Communications|February 27, 2022
Preoperative portal vein recanalization-transjugular intrahepatic portosystemic shunt for chronic obliterative portal vein thrombosis: Outcomes following liver transplantationAbhinav Talwar, Jeffrey Varghese, Gabriel M Knight, et al.
JMIR Research Protocols|September 14, 2016
EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell AnemiaAngela E Rankine-Mullings, Courtney R Little, Marvin E Reid, et al.
Biomaterials|September 3, 2005
Multiple-channel scaffolds to promote spinal cord axon regenerationMichael J Moore, Jonathan A Friedman, Eric B Lewellyn, et al.
Journal of Clinical Microbiology|October 9, 2025
<i>In vitro</i> activity of antibiotic monotherapy and combination therapy with bacteriophages against <i>Staphylococcus aureus</i> LVAD-driveline infectionsMichèle M Molendijk, Nelianne J Verkaik, Corné P de Vogel, et al.
Communications Medicine|May 23, 2022
Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapyJennifer M Knight, Aniko Szabo, Igli Arapi, et al.
Pageof 115